ghk-cu virus - Research Peptide GHK-Cu (Copper Tripeptide) - Skin

Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture

The peptide mimics a naturally occurring substance derived from the pineal gland and has shown powerful longevity-enhancing effects in both animal and human studies

pharmacies and is not available through PeptidePrescript

For appetite suppression, GLP-1s like Semaglutide and Tirzepatide remain the clinical standard